Daiwa Securities Group Inc. - PARATEK PHARMACEUTICALS INC ownership

PARATEK PHARMACEUTICALS INC's ticker is PRTK and the CUSIP is 699374302. A total of 114 filers reported holding PARATEK PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 2.75 and the average weighting 0.5%.

Quarter-by-quarter ownership
Daiwa Securities Group Inc. ownership history of PARATEK PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2022$0860.0%0.00%
Q2 2022$0860.0%0.00%
Q1 2022$0860.0%0.00%
Q4 2021$0860.0%0.00%
Q3 2021$0
-100.0%
860.0%0.00%
Q2 2021$1,0000.0%860.0%0.00%
Q1 2021$1,0000.0%860.0%0.00%
Q4 2020$1,0000.0%86
-50.3%
0.00%
Q3 2019$1,0000.0%1730.0%0.00%
Q2 2019$1,0000.0%1730.0%0.00%
Q1 2019$1,0000.0%1730.0%0.00%
Q4 2018$1,000
-50.0%
1730.0%0.00%
Q3 2018$2,0000.0%1730.0%0.00%
Q2 2018$2,0000.0%1730.0%0.00%
Q1 2018$2,0001730.00%
Other shareholders
PARATEK PHARMACEUTICALS INC shareholders Q1 2018
NameSharesValueWeighting ↓
AIGH Capital Management LLC 2,339,107$10,502,0003.20%
Telemetry Investments, L.L.C. 262,279$1,178,0001.52%
Bruce & Co., Inc. 1,443,312$6,480,0001.30%
Omega Fund Management, LLC 1,971,241$8,851,0001.25%
Worth Venture Partners, LLC 556,832$2,500,0001.24%
Abingworth LLP 1,041,131$4,654,0001.13%
1492 Capital Management LLC 491,033$2,205,0001.09%
CM Management, LLC 300,000$1,347,0001.02%
Trellus Management Company, LLC 295,000$1,325,0000.88%
GENERAL AMERICAN INVESTORS CO INC 1,306,919$5,868,0000.46%
View complete list of PARATEK PHARMACEUTICALS INC shareholders